← Open Payments lookup

SARA EAKIN: Open Payments

NPI 1477037042 · TEMPLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,614 in 22 payments from 10 companies in 2025. Trend: 2023 $775 · 2024 $1,077 · 2025 $2,614

Food & beverage: $1,956Travel & lodging: $658
CompanyPaymentsAmount
Enterra Medical, Inc.5$1,275
GENZYME CORPORATION3$354
ABBVIE INC.5$335
Janssen Biotech, Inc.2$149
PFIZER INC.1$108
Ipsen Biopharmaceuticals, Inc1$96
Takeda Pharmaceuticals U.S.A., Inc.1$96
Dexcom, Inc.2$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$85
Aimmune Therapeutics, Inc.1$29

Products named: DUPIXENT, SKYRIZI, TREMFYA, VELSIPITY, IQIRVO, ENTYVIO, Dexcom G6 Transmitter, XIFAXAN.

Industry payments across TX — which companies pay providers there.